How to Choose a GLP-1: A Decision Guide

Reading time
4 min
Published on
July 13, 2026
Updated on
July 13, 2026
How to Choose a GLP-1: A Decision Guide

The best GLP-1 for you comes down to a few personal factors: how much weight you want to lose, how well you tolerate side effects, whether you prefer a pill or an injection, what you can afford, and your other health conditions. Tirzepatide (Zepbound, Mounjaro) tends to produce the most weight loss, while semaglutide (Wegovy, Ozempic) is well-established and sometimes costs less. Research shows these drugs work well across ages, races, and starting weights, so the decision is less about who you are and more about your goals and preferences. Here’s how to think it through.

Start With Your Goal

The size of your weight loss goal is a reasonable first filter. If you have a lot to lose or want the largest average result, tirzepatide leads among approved options, with trial averages around 20%. If your goal is more moderate, semaglutide (around 15%) may be plenty, especially if cost or availability points you there. Neither is a wrong choice; they’re different points on the same spectrum.

Reassuringly, the drugs work broadly. In a systematic review and meta-analysis published in JAMA Internal Medicine in 2026, GLP-1 medications produced consistent weight loss across age, race, ethnicity, and starting BMI, with women losing a somewhat larger percentage than men. In practice, that means your demographics shouldn’t steer the choice much. Your priorities should.

Weigh the Practical Factors

Factor Points toward Why
Largest weight loss Tirzepatide Highest average results among approved drugs
Lower cost Semaglutide or self-pay options Often priced below tirzepatide
Sensitive stomach Slow titration, either drug Tirzepatide had slightly fewer GI discontinuations in trials
Prefer a pill Oral options (via manufacturer) Needle-free, though generally less potent
Sleep apnea with obesity Tirzepatide (Zepbound) The only drug approved for moderate-to-severe OSA

TrimRx prescribes compounded semaglutide and compounded tirzepatide along with the brand injectables, so both leading options are available after a provider review. A few decision points are worth spelling out.

Tolerability is manageable for most people regardless of which you pick, and how you start (a low dose, increased slowly) matters more than the drug itself. Route is a real preference: the strongest options are weekly injections with a small needle, while oral GLP-1s exist for the needle-averse but are available through their manufacturers rather than TrimRx and tend to produce less weight loss. Cost varies by drug and channel, and because TrimRx is cash-pay, you won’t be dealing with insurance approvals. Finally, your health conditions can tip the scales: someone with obesity and sleep apnea has a clear reason to consider tirzepatide, since it’s the only drug approved for that use.

Consider a hypothetical patient deciding between the two. She has about 40 pounds to lose, a limited budget, and no needle phobia. Semaglutide could be a sensible, cost-conscious starting point, with the option to switch to tirzepatide later if her results stall. A different patient with 90 pounds to lose and sleep apnea might reasonably start with tirzepatide from the outset. You can read more about the service on the TrimRx homepage.

You Can Change Course

Choosing a GLP-1 isn’t a permanent commitment. Many people start with one drug and switch based on results and tolerance, which a provider can manage with appropriate dose adjustments. Treating the first choice as a starting point rather than a final verdict takes some pressure off the decision.

Frequently Asked Questions

Should I choose semaglutide or tirzepatide?

Tirzepatide produces more weight loss on average, while semaglutide is well-established and may cost less. If your goal is large or you have sleep apnea, tirzepatide has an edge; if cost matters most, semaglutide is a strong, proven option.

Does it matter which GLP-1 I pick if I have a specific health condition?

Sometimes. Tirzepatide is the only drug approved for moderate-to-severe sleep apnea with obesity, and both drugs help with conditions like insulin resistance and high blood pressure. Your other conditions can reasonably guide the choice.

Can I switch GLP-1s if the first one doesn’t work well?

Yes. Switching is common and manageable with a provider’s guidance, including a proper dose adjustment. Many people change medications based on results or tolerance.

To see which option fits your goals, you can take the TrimRx quiz for a licensed provider’s review.

This article is for educational purposes and is not medical advice. Choosing a weight loss medication should be done with a qualified healthcare provider. Oral GLP-1 options are available through their manufacturers, not TrimRx. Individual results vary.

Transforming Lives, One Step at a Time

Patients on TrimRx can maintain the WEIGHT OFF
Start Your Treatment Now!

Keep reading

4 min read

CagriSema vs Orforglipron: Combination Injection Versus Convenient Pill

This comparison captures a classic trade-off: CagriSema is a powerful combination injection that produces far more weight loss, while orforglipron is a simple daily…

4 min read

The Oral GLP-1 Pills Coming Soon: Orforglipron, Amycretin, and VK2735 Compared

The era of the weight-loss pill has arrived, and three names lead the next wave: orforglipron (already approved), amycretin, and VK2735 (both investigational). All…

4 min read

Is Orforglipron FDA Approved Yet? Timeline and What to Expect

Yes. Orforglipron was approved by the FDA on April 1, 2026, and is sold under the brand name Foundayo. It’s approved for adults with…

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.